Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients

被引：0
|
作者：
Koppaka, D. [1 ]
Kuntegowdanahalli, L. C. [1 ]
Lokanath, D. [1 ]
Babu, K. Govind [1 ]
Jacob, L. A. [1 ]
Babu, M. C. Suresh [1 ]
Lokesh, K. N. [1 ]
Rudresha, A. H. [1 ]
Rajeev, L. K. [1 ]
Smitha, S. C. [1 ]
Anand, A. [1 ]
Asati, V. [1 ]
Chethan, R. [1 ]
Patidar, R. [1 ]
Chaudhuri, T. [1 ]
Kasturi, A. [2 ]
机构：
[1] Kidwai Canc Inst, Med Oncol, Bengaluru, India
[2] Cloudnine Hosp, Dept Anaesthesia, Bengaluru, India
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
421O
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [31] Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia
    Shin Ahn
    Yoon-Seon Lee
    Kyung Soo Lim
    Jae-Lyun Lee
    Supportive Care in Cancer, 2013, 21 : 2303 - 2308
  • [32] Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Lim, Kyung Soo
    Lee, Jae-Lyun
    SUPPORTIVE CARE IN CANCER, 2013, 21 (08) : 2303 - 2308
  • [33] COMPARISON OF THE SIDE EFFECTS OF ANTIBIOTICS IN PATIENTS WITH THE DIAGNOSIS OF FEBRILE NEUTROPENIA
    Kurt, H.
    Ergene, U.
    HAEMATOLOGICA, 2012, 97 : 572 - 572
  • [34] Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile Neutropenia
    Mayer, Karin
    Hegge, Nicolaus
    Molitor, Ernst
    Brossart, Peter
    Hahn-Ast, Corinna
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14
  • [35] COMPARISON OF THE SIDE EFFECTS OF ANTIBIOTICS IN PATIENTS WITH THE DIAGNOSIS OF FEBRILE NEUTROPENIA
    Kurt, H.
    Ergene, U.
    HAEMATOLOGICA, 2013, 98 : 724 - 724
  • [36] Assessment of chemotherapy-induced febrile neutropenia in cancer patients
    Philip, Malona Lilly
    Saj, Neethu
    Sebastian, Antony Mathew
    Mateti, Uday Venkat
    Shetty, Vijith
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (02) : 249 - 256
  • [37] A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy
    Lyman, GH
    Crawford, J
    Wolff, DA
    Culakova, E
    Poniewierski, MS
    Dale, DC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 759S - 759S
  • [38] A COMPARISON OF ORAL LEVOFLOXACIN AND CEFEPIME IN PATIENTS WITH LOW-RISK FEBRILE NEUTROPENIA BY THE JAPAN FEBRILE NEUTROPENIA STUDY GROUP
    Yoshida, I.
    Tamura, K.
    Oze, I.
    Takahashi, T.
    Hino, M.
    Hatanaka, K.
    Nakao, Y.
    Narumi, H.
    Itoh, T.
    Ohyashiki, K.
    Tanimoto, M.
    Urabe, A.
    Kanamaru, A.
    Masaoka, T.
    HAEMATOLOGICA, 2015, 100 : 466 - 466
  • [39] A new prognostic model for chemotherapy-induced febrile neutropenia
    Shin Ahn
    Yoon-Seon Lee
    Jae-Lyun Lee
    Kyung Soo Lim
    Sung-Cheol Yoon
    International Journal of Clinical Oncology, 2016, 21 : 46 - 52
  • [40] A new prognostic model for chemotherapy-induced febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Lee, Jae-Lyun
    Lim, Kyung Soo
    Yoon, Sung-Cheol
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (01) : 46 - 52
12345